Atea Pharmaceuticals Stock Story

AVIR -  USA Stock  

USD 24.78  0.33  1.31%

Atea Pharmaceuticals Stock News module provides quick insight into current market opportunities from investing in Atea Pharmaceuticals. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Atea Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Please continue to Atea Pharmaceuticals Hype Analysis, Atea Pharmaceuticals Correlation and Atea Pharmaceuticals Performance.

Search Today's Stock News 

 
Refresh
Atea Pharmaceuticals stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Atea Pharmaceuticals daily returns and investor perception about the current pice of Atea Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
Conversion by Chu Chung K of 43859 shares of Atea Pharmaceuticals
Filed transaction by Atea Pharmaceuticals Inc executive. Derivative codes conversion of derivative security

Atea Pharmaceuticals insider trading alert for conversion of series c convertible preferred stock by Chu Chung K, the corporate stakeholder, on 3rd of November 2020. This event was filed by Atea Pharmaceuticals Inc with SEC on 2020-11-03. Statement of changes in beneficial ownership - SEC Form 4

Cash Floor Correlation

Click cells to compare fundamentals

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Atea Pharmaceuticals Fundamental Analysis

We analyze Atea Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Atea Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Atea Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Working Capital

Working Capital Comparative Analysis

Atea Pharmaceuticals is currently under evaluation in working capital category among related companies. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .

Atea Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Atea Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Atea Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Atea Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Atea Pharmaceuticals Related Equities

EQ
EQEquillium   0.18   
0%
1.0%
DRNA
DRNADicerna Pharmaceutic   0.59   
5.0%
0%
DSGN
DSGNDesign Therapeutics   1.20   
10.0%
0%
EARS
EARSAuris Medical   1.61   
14.0%
0%
DVAX
DVAXDynavax Technologies   1.80   
15.0%
0%
DTIL
DTILPrecision Biosciences   1.85   
16.0%
0%
DYAI
DYAIDyadic International   1.96   
17.0%
0%
EDIT
EDITEditas Medicine   2.03   
18.0%
0%
DMAC
DMACDiamedica Therapeutics   3.79   
33.0%
0%
DNLI
DNLIDenali Therapeutics   11.24   
100.0%
0%
Please continue to Atea Pharmaceuticals Hype Analysis, Atea Pharmaceuticals Correlation and Atea Pharmaceuticals Performance. Note that the Atea Pharmaceuticals information on this page should be used as a complementary analysis to other Atea Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Atea Pharmaceuticals Stock analysis

When running Atea Pharmaceuticals price analysis, check to measure Atea Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea Pharmaceuticals is operating at the current time. Most of Atea Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Atea Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Atea Pharmaceuticals' price. Additionally, you may evaluate how the addition of Atea Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
The market value of Atea Pharmaceuticals is measured differently than its book value, which is the value of Atea Pharmaceuticals that is recorded on the company's balance sheet. Investors also form their own opinion of Atea Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Atea Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atea Pharmaceuticals' market value can be influenced by many factors that don't directly affect Atea Pharmaceuticals underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atea Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Atea Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atea Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.